Neonc Technologies Holdings Inc (NTHI)

$12.00 -0.11 (-0.91%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 9,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary b...

Industry: Biotechnology
Sector: Healthcare
Phone: 310-663-7831
Address:
23975 Park Sorrento, Suite 205, Calabasas, United States
Evey
Evey Jul. 16 at 2:09 AM
$NTHI finally close green. Up and onwards back to 6🙏
0 · Reply
Justjohnn
Justjohnn Jul. 15 at 12:37 PM
$NTHI Well this is turning into a turd, eh?
0 · Reply
Moses55
Moses55 Jul. 11 at 6:44 PM
$NTHI get ready
2 · Reply
Moses55
Moses55 Jul. 11 at 6:21 PM
$NTHI 6+ if not 10
2 · Reply
Justjohnn
Justjohnn Jul. 11 at 5:03 PM
$NTHI is it gonna break $5 today?
0 · Reply
Evey
Evey Jul. 11 at 3:04 AM
$NTHI news out AH!!
1 · Reply
BLACKFEATHER
BLACKFEATHER Jul. 10 at 8:27 PM
$NTHI any hope for AH? This shit ate me up this morning
3 · Reply
Goatcheese
Goatcheese Jul. 10 at 7:25 PM
$NTHI need more coffee and research before trading this one -
0 · Reply
Snorlaxzpower
Snorlaxzpower Jul. 10 at 2:50 PM
$NTHI it looks pretty strong
0 · Reply
homeal
homeal Jul. 10 at 2:01 PM
$NTHI 4$ today
0 · Reply
Latest News on NTHI
NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform

Jul 8, 2025, 9:00 AM EDT - 8 days ago

NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

Jun 6, 2025, 9:00 AM EDT - 5 weeks ago

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

Apr 15, 2025, 8:05 AM EDT - 3 months ago

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

Apr 14, 2025, 8:05 AM EDT - 3 months ago

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

Apr 10, 2025, 8:05 AM EDT - 3 months ago

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

Apr 8, 2025, 4:05 PM EDT - 3 months ago

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

Mar 31, 2025, 8:05 AM EDT - 3 months ago

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

Mar 27, 2025, 8:05 AM EDT - 3 months ago

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors

Mar 25, 2025, 8:45 AM EDT - 4 months ago

NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors

NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors

Mar 25, 2025, 8:15 AM EDT - 4 months ago

NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

Jan 4, 2025, 12:30 AM EST - 6 months ago

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

AERO CAPS CRGT FBGL FLOC INLF INR

NeOnc Technologies Receives Pharma Tech Outlook's Top Drug Delivery Platform Award for 2024

Oct 7, 2024, 11:00 AM EDT - 10 months ago

NeOnc Technologies Receives Pharma Tech Outlook's Top Drug Delivery Platform Award for 2024

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate

Aug 5, 2024, 11:00 AM EDT - 1 year ago

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate

NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation

Jul 16, 2024, 11:15 AM EDT - 1 year ago

NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status

Jun 26, 2024, 4:39 PM EDT - 1 year ago

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status

NeOnc Technologies Wins California Investment Forum's Breakthrough Medical Technology Achievement Award

May 15, 2024, 11:00 AM EDT - 1 year ago

NeOnc Technologies Wins California Investment Forum's Breakthrough Medical Technology Achievement Award

NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10

May 9, 2024, 5:30 PM EDT - 1 year ago

NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

Mar 30, 2024, 1:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

BOLD MMA MNDR NTCL ROTR UBXG WAY

U.S. IPO Weekly Recap: Small Japanese Lists In The US As Insurer Aspen Holdings Joins The IPO Pipeline

Dec 25, 2023, 9:05 AM EST - 1 year ago

U.S. IPO Weekly Recap: Small Japanese Lists In The US As Insurer Aspen Holdings Joins The IPO Pipeline

LGCB MAMO LZMH

Neonc Technologies Seeks U.S. IPO For Brain Cancer Treatment Pipeline

Dec 20, 2023, 2:38 PM EST - 1 year ago

Neonc Technologies Seeks U.S. IPO For Brain Cancer Treatment Pipeline

Evey
Evey Jul. 16 at 2:09 AM
$NTHI finally close green. Up and onwards back to 6🙏
0 · Reply
Justjohnn
Justjohnn Jul. 15 at 12:37 PM
$NTHI Well this is turning into a turd, eh?
0 · Reply
Moses55
Moses55 Jul. 11 at 6:44 PM
$NTHI get ready
2 · Reply
Moses55
Moses55 Jul. 11 at 6:21 PM
$NTHI 6+ if not 10
2 · Reply
Justjohnn
Justjohnn Jul. 11 at 5:03 PM
$NTHI is it gonna break $5 today?
0 · Reply
Evey
Evey Jul. 11 at 3:04 AM
$NTHI news out AH!!
1 · Reply
BLACKFEATHER
BLACKFEATHER Jul. 10 at 8:27 PM
$NTHI any hope for AH? This shit ate me up this morning
3 · Reply
Goatcheese
Goatcheese Jul. 10 at 7:25 PM
$NTHI need more coffee and research before trading this one -
0 · Reply
Snorlaxzpower
Snorlaxzpower Jul. 10 at 2:50 PM
$NTHI it looks pretty strong
0 · Reply
homeal
homeal Jul. 10 at 2:01 PM
$NTHI 4$ today
0 · Reply
homeal
homeal Jul. 10 at 1:56 PM
$NTHI Trash. Crying bulls
0 · Reply
RocketScience2023
RocketScience2023 Jul. 10 at 1:56 PM
$NTHI I am glad I moved my order down and did not fill. Lots of new bagholders in here this morning.
0 · Reply
Dexter79
Dexter79 Jul. 10 at 1:53 PM
$NTHI BTCM done. Let's hope bulls will look at this now...
0 · Reply
homeal
homeal Jul. 10 at 1:53 PM
$NTHI a garbage company. Go away. see you at 1$
0 · Reply
LouieSparks
LouieSparks Jul. 10 at 1:51 PM
$NTHI genuinely asking, can somebody explain to me why this one popped but nobody cared? 2m float, ok catalyst, looked like it was setting up a flag but then just poof, nothing?
1 · Reply
BLACKFEATHER
BLACKFEATHER Jul. 10 at 1:49 PM
$NTHI if that ain't a punch to the gut...
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 10 at 1:47 PM
$NTHI has stumbled -16% lower to -9% (~3Mv) moments ago, follow for more volatility.
0 · Reply
hegoodma
hegoodma Jul. 10 at 1:47 PM
$NTHI I think it’s coming back guys…
0 · Reply
Dexter79
Dexter79 Jul. 10 at 1:45 PM
$NTHI it's a shame....
0 · Reply
homeal
homeal Jul. 10 at 1:40 PM
$NTHI thx 30% short kk
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 10 at 1:37 PM
$NTHI -13%[8%] $SOBR 10%[-13%] $SYTA -8%[-6%] $AEHR 8%[9%] $AIRI -7%[11%] most notable movement within the first minutes of trading.
0 · Reply
homeal
homeal Jul. 10 at 1:37 PM
$NTHI easy short
0 · Reply